LINC01619

Across TCGA pan-cancer cohorts, LINC01619 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of LINC01619’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where LINC01619 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01619 is over-expressed in tumor, although a few such as BRCA and UCEC show the opposite, repressed pattern.

HNSC, KIRC, and BRCA are the cancer types where LINC01619 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01619 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	All	+0.332	<.001	11	view →
KIRC	All	II,III,IV	+0.373	<.001	10	view →
BRCA	All	III,IV	−0.630	<.001	6	view →
UCEC	All	All	−0.265	<.001	6	view →
KICH	All	All	−0.361	<.001	4	view →
STAD	Male	All	+0.183	.005	4	view →
CHOL	All	All	+1.073	<.001	3	view →
LUAD	Female	II,III,IV	−0.324	<.001	3	view →
LUSC	All	All	+0.282	.006	3	view →
LIHC	All	All	+0.246	.029	2	view →
COAD	Female	III,IV	−0.208	.036	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

LINC01619–HNSC

Open the HNSC breakdown →